Intern, HEOR (Remote)
Boehringer Ingelheim
Summary
Boehringer Ingelheim is currently seeking a talented and innovative Summer Intern to join our HEOR Value Demonstration Team for a remote position. In this role, you will support Health Economics and Outcomes Research (HEOR) activities across oncology and respiratory disease therapeutic areas. As an intern, you will be deeply involved with the HEOR team, working with colleagues to understand and shape the value proposition of our oncology and respiratory diseases assets and pipelines. The intern will assist with research projects, data analysis, literature reviews, and the development of presentations and scientific materials. You will also collaborate with cross-functional teams and gain valuable hands-on experience in HEOR and its role in pharmaceutical and healthcare decision-making.
Job description
Description
Boehringer Ingelheim is currently seeking a talented and innovative Summer Intern to join our HEOR Value Demonstration Team for a remote position. In this role, you will support Health Economics and Outcomes Research (HEOR) activities across oncology and respiratory disease therapeutic areas. As an intern, you will be deeply involved with the HEOR team, working with colleagues to understand and shape the value proposition of our oncology and respiratory diseases assets and pipelines. The intern will assist with research projects, data analysis, literature reviews, and the development of presentations and scientific materials. You will also collaborate with cross-functional teams and gain valuable hands-on experience in HEOR and its role in pharmaceutical and healthcare decision-making.
Duties & Responsibilities
- Assist in conducting diverse HEOR studies in oncology and respiratory disease therapeutic areas, including real-world evidence studies, retrospective database analyses, economic modeling, meta-analyses and systematic literature reviews to assess treatment patterns, clinical outcomes, healthcare resource utilization and economic burden
- Participate in all phases of oncology and respiratory disease HEOR studies, from study conceptualization, research question formulation, and protocol development to statistical analysis, vendor management, and scientific dissemination
- Collaborate with cross-functional partners, including medical affairs, market access, commercial, and field teams, to develop strategic and tactical evidence generation supporting oncology and respiratory disease therapeutic portfolios, payer value propositions, and evidence-based healthcare decision making
- Aid development of impactful scientific presentations, slide decks, evidence summaries and communication materials highlighting clinical, humanistic, and economic outcomes in oncology and respiratory disease therapeutic areas
- Engage in therapeutic area, departmental and cross-functional meetings to strengthen understanding of oncology and respiratory disease landscapes, and the role HEOR plays in supporting Boehringer Ingelheim's research, development, and commercialization objectives
Requirements
- Must be a current undergraduate, graduate or advanced degree student in good academic standing
- Student must be enrolled at an accredited college or university for the duration of the internship
- Overall cumulative minimum GPA from last completed quarter/semester 3.0 GPA (on a 4.0 scale) preferred
- Major in a related field such as HEOR, Pharmacy, Epidemiology, or Health Services Research for this internship
- Undergraduate students must have completed at least 12 credit hours at current college or university
- Graduate and advanced degree students must have completed at least 9 credit hours at current college or university
- Must be legally authorized to work in the United States without restriction
- Must be willing to take a drug test and post-offer physical (if required)
- Must be 18 years of age or older
Desired Skills, Experience and Abilities
- Prior research experience in conducting literature reviews, economic modelling, and real-world evidence studies. Relevant advanced coursework in areas such as, but not limited to, health economics, epidemiology, biostatistics, and/or research methods
- Demonstrated excellent oral and written communication skills and strong analytical and problem-solving skills
- Comfortable working in a team-oriented environment
- Proactive attitude and eagerness to contribute
Requirements
- Must be a current undergraduate, graduate or advanced degree student in good academic standing
- Student must be enrolled at an accredited college or university for the duration of the internship
- Overall cumulative minimum GPA of 3.0 (on a 4.0 scale) preferred
- Major in a related field such as HEOR, Pharmacy, Epidemiology, or Health Services Research
- Undergraduate students must have completed at least 12 credit hours at current college or university
- Graduate and advanced degree students must have completed at least 9 credit hours at current college or university
- Must be legally authorized to work in the United States without restriction
- Must be willing to take a drug test and post-offer physical (if required)
- Must be 18 years of age or older
- Prior research experience in conducting literature reviews, economic modelling, and real-world evidence studies
- Relevant advanced coursework in health economics, epidemiology, biostatistics, and/or research methods
- Demonstrated excellent oral and written communication skills
- Strong analytical and problem-solving skills
- Comfortable working in a team-oriented environment
- Proactive attitude and eagerness to contribute
Benefits
- Competitive Compensation
- Work-Life Balance
- Networking Opportunities
Company overview
Boehringer Ingelheim is a leading global research-driven biopharmaceutical company founded in 1885 and headquartered in Ingelheim am Rhein, Germany. As one of the world's top 20 pharmaceutical companies and the largest privately-owned pharmaceutical firm, it operates across three main business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. The company focuses on developing innovative therapies for diseases with high unmet medical needs, including cardiometabolic diseases, oncology, respiratory diseases, immunology, central nervous system disorders, and retinal health. With over 54,500 employees across 78 countries, Boehringer Ingelheim generated approximately €26.8 billion in revenue in 2024. The company maintains a strong research and development network with facilities in Germany, the United States, Austria, Japan, and Switzerland, investing significantly in advancing treatments for both human and animal health. Notable products include Jardiance (empagliflozin) for diabetes, Ofev (nintedanib) for pulmonary fibrosis, Spiriva (tiotropium) for respiratory conditions, and Pradaxa (dabigatran) for anticoagulation therapy.